FLF’s Chief Medical Officer’s top highlights from American Society of Hematology (ASH) 2023 Annual Meeting
Mitchell Smith, M.D., PhD
Chief Medical Officer, FLF
February 2024
Dr Mitchell Smith. FLF CMO, shares his top highlights from ASH 2023 in San Diego including what to expect in the FL field in 2024.
He focuses on three interconnected themes:
1.Immunotherapy: How good is it? How to improve?
2.Can we make better CAR-Ts or better Bispecific antibodies?
- 3.Molecular testing of measurable minimal residual disease (MRD)
For a more detailed forward-looking view of what the future holds for FL research, take a look at Dr Smith’s recent report, “Follicular Lymphoma: Navigating the Pathways for Clinical and Translational Investigations” found below.
Overall, Dr Smith cites ASH 2023 as exciting hearing about new advances leading to better treatment for patients, and research towards finding a cure for FL.